Search Within

Inaki Etxeberria

Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
  3. Review (1)
Groups
  1. Sloan Kettering Institute Postdocs (8)
  2. Breast Medicine Service (7)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (7)
  4. Department of Medicine (7)
  5. GSK Faculty (7)
  6. Hematologic Malignancies, Division of (7)

More Groups

People
  1. Christopher Klebanoff (7)
  2. Smita Chandran (4)
  3. Alexander Drilon (2)
  4. Alexander Lewis (2)
  5. Anthony Daniyan (2)
  6. Beatrice Zhang (2)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (2)
Publications
  1. Blood (1)
  2. Cell (1)
  3. Immuno-Oncology and Technology (1)
  4. Journal for ImmunoTherapy of Cancer (1)
  5. Nature (1)
  6. Nature Medicine (1)

More Publications

Publishers
  1. Nature Publishing Group (2)
  2. American Society of Hematology (1)
  3. Biomed Central Ltd (1)
  4. Cell Press (1)
  5. Elsevier Inc. (1)
  6. Elsevier Ltd (1)

More Publishers

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias
    Journal Article

    Kim, W. J.; Crosse, E. I.; De Neef, E.; Etxeberria, I.; Sabio, E. Y.; Wang, E.; Bewersdorf, J. P.; Lin, K. T.; Lu, S. X.; Belleville, A.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • Tumour-wide RNA splicing aberrations generate actionable public neoantigens
    Journal Article

    Kwok, D. W.; Stevers, N. O.; Etxeberria, I.; Nejo, T.; Colton Cove, M.; Chen, L. H.; Jung, J.; Okada, K.; Lakshmanachetty, S.; Gallus, M.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • Enhancing the persistence and anti-tumor efficacy of CAR-T and CAR-NK cells through genetic disruption of death receptors
    Meeting Abstract

    Cohen, T. D.; Yi, F.; Zumbo, P.; Etilib, R.; Arkin, H.; Gormally, M.; Hackett, C. S.; Kropp, K.; Etxeberria, I.; Chandran, S. S.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Mis-splicing derived neoantigens and cognate T cell receptors in splicing factor mutant myeloid neoplasms
    Meeting Abstract

    Kim, W. J.; Crosse, E. I.; De Neef, E.; Etxeberria, I.; Sabio, E.; Wang, E.; Bewersdorf, J. P.; Lu, S. X.; Belleville, A.; Fox, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Regional and intratumoral adoptive T-cell therapy
    Review

    Olivera, I.; Etxeberria, I.; Luri-Rey, C.; Molero-Glez, P.; Melero, I.
    Immuno-Oncology and Technology (2024)

    Fulltext@MSK | Save
  • Public tumor-wide neoantigens derived from clonal aberrant splicing events drive tumor-specific T-cell responses
    Meeting Abstract

    Kwok, D.; Stevers, N.; Nejo, T.; Jung, J.; Chen, L.; Lakshmanachetty, S.; Etxeberria, I.; Gallus, M.; Yamamichi, A.; Ramos, E.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Immunogenic landscape and therapeutic targeting of mutant NRAS "public" neoantigens
    Meeting Abstract

    Etxeberria, I.; Banks, L.; Chandran, S.; Correa, A.; Novak, B.; Fleischman, J.; Drilon, A.; Wolchok, J.; Merghoub, T.; Klebanoff, C.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
    Journal Article

    Chandran, S. S.; Ma, J.; Klatt, M. G.; Dündar, F.; Bandlamudi, C.; Razavi, P.; Wen, H. Y.; Weigelt, B.; Zumbo, P.; Fu, S. N.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save